BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17075813)

  • 21. Clinical significance of autoantibodies to double-stranded DNA tested by Crithidia luciliae method in systemic lupus erythematosus patients.
    Liu HW
    Taiwan Yi Xue Hui Za Zhi; 1982 Mar; 81(3):380-7. PubMed ID: 7050293
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal transplantation in systemic lupus erythematosus.
    Yakub YN; Freeman RB; Pabico RC
    Nephron; 1981; 27(4-5):197-201. PubMed ID: 7022239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features of systemic lupus erythematosus patients with antihistone antibodies.
    Fritzler M; Ryan P; Kinsella TD
    J Rheumatol; 1982; 9(1):46-51. PubMed ID: 7086779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-DNA antibody: origin and impact, dogmas and controversies.
    Rekvig OP
    Nat Rev Rheumatol; 2015 Sep; 11(9):530-40. PubMed ID: 26034836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunofluorescent method of detection of antibodies to native DNA using the Crithidia luciliae flagellate as substrate].
    Maldyk E
    Pol Tyg Lek; 1976 Oct; 31(42):1819-20. PubMed ID: 792832
    [No Abstract]   [Full Text] [Related]  

  • 26. [Systemic lupus erythematosus between clinical practice and the laboratory: state of the art and new findings on anti-DNA autoantibodies].
    Brusca I; Corrao S; Li Vigni P; Sucato R; La Chiusa SM
    Recenti Prog Med; 2002 Jun; 93(6):377-87. PubMed ID: 12085719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological correlations with nephritis in systemic lupus erythematosus.
    Reichlin M
    Clin Immunol; 2005 Oct; 117(1):12-4. PubMed ID: 16006192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Function and significance of B-lymphocyte defects in the pathogenesis of systemic lupus erythematosus].
    Wollina U
    Dermatol Monatsschr; 1984; 170(2):81-90. PubMed ID: 6202566
    [No Abstract]   [Full Text] [Related]  

  • 29. Perspectives on systemic lupus erythematosus (SLE)--a model for autoimmunity.
    Stollar BD
    Isr J Med Sci; 1988 Jul; 24(7):352-5. PubMed ID: 3261283
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular mimicry in systemic lupus erythematosus.
    Agmon-Levin N; Blank M; Paz Z; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1181-5. PubMed ID: 19880565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changing concepts of disseminated lupus erythematosus].
    Tron F; Bach JF
    Nouv Presse Med; 1980 Sep; 9(33):2315-8. PubMed ID: 7433021
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoantibody and clinical profiles in patients with discoid lupus and borderline systemic lupus.
    Vasquez R; Tseng LC; Victor S; Zhang S; Chong BF
    Arch Dermatol; 2012 May; 148(5):651-5. PubMed ID: 22782164
    [No Abstract]   [Full Text] [Related]  

  • 33. Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus.
    van Bavel CC; Fenton KA; Rekvig OP; van der Vlag J; Berden JH
    Arthritis Rheum; 2008 Jul; 58(7):1892-9. PubMed ID: 18576314
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
    J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood-onset systemic lupus erythematosus: early disease manifestations that the paediatrician must know.
    Silva CA
    Expert Rev Clin Immunol; 2016 Sep; 12(9):907-10. PubMed ID: 27249622
    [No Abstract]   [Full Text] [Related]  

  • 36. Extracorporeal removal of anti-DNA antibodies in systemic lupus erythematosus using DNA-collagen films.
    Laville M; el Habib R; Traeger J; Coulet PR; Gautheron DC; Sanhadji K; My H; Zech PY
    Life Support Syst; 1983; 1 Suppl 1():65-70. PubMed ID: 6400735
    [No Abstract]   [Full Text] [Related]  

  • 37. Re-establishment of tolerance: the prospect of developing specific treatment for human lupus.
    Katsiari CG; Tsokos GC
    Lupus; 2004; 13(7):485-8. PubMed ID: 15352417
    [No Abstract]   [Full Text] [Related]  

  • 38. Can we use DNA triple helices as treatment for systemic lupus erythematosus?
    Mikita CP; Padlan EA
    Med Hypotheses; 2014 Apr; 82(4):457-9. PubMed ID: 24513158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Systemic lupus erythematosus--still current clinical and diagnostic problem].
    Gesikowska K; Kondera-Anasz Z; Mielczarek-Palacz A; Sikora J; Machaj I; Smycz M
    Pol Merkur Lekarski; 2012 Feb; 32(188):111-5. PubMed ID: 22590915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of anti-DNA antibodies in the diagnosis and treatment of systemic lupus erythematosus].
    Egido De Los Rios J; García Sáchez M; Sánchez Crespo M; Losada M; Pallardo L; Hernando L
    Rev Clin Esp; 1978 Nov; 151(4):265-71. PubMed ID: 311068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.